$ALV

Why Autoliv (ALV) Stock Is Trading Lower Today

Autoliv (NYSE: ALV) shares fell about 3% to close at $120.25 after its Q2 results missed profit expectations. Adjusted EPS was $2.43 versus about $2.46 consensus, despite revenue beating forecasts. A $90 million restructuring charge tied to exiting manufacturing in Türkiye drove a 40% drop in net income and 38% lower diluted EPS. Autoliv Americas President Kevin Fox plans to step down.

Original reporting
Published Jul 17, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 17, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Autoliv (ALV) Stock Is Trading Lower Today — source image
Decision brief

The 30-second read

$ALVBearishMed
01

Why it matters

The $90M restructuring charge drove a sharp decline in reported net income and EPS, and the stock sold off on the afternoon session. An additional executive step-down was also announced.

02

Market read

Traders can reassess near-term earnings quality and restructuring execution risk after today’s Q2 miss and the explicit Türkiye exit charge.

03

What to watch

The article does not quantify expected savings from the Türkiye exit or provide guidance, so the market reaction could be incomplete without management’s forward plan.

Relevance 8/10Novelty 7/10Timing: after-hours/afternoon reaction to Q2 results reported today

Background

Autoliv reported Q2 results with revenue topping forecasts but adjusted earnings missing consensus, alongside a planned manufacturing exit in Türkiye.

Company-level read

Ticker impact

$ALVBearishMedium confidence
Context

Autoliv shares fell after Q2 results missed profit expectations, with a $90M restructuring charge tied to an exit from manufacturing in Türkiye.

Expected impact

Near-term downside bias versus peers until investors get clarity on restructuring timeline and margin recovery.

Evidence & confidence

The article cites a specific $90M charge, EPS decline, and an afternoon selloff of about 3.2% to 3.8%, indicating the market is reacting directly to the reported quarter and restructuring costs.

Market effects

Highlights how restructuring charges can dominate autosupplier earnings, potentially increasing scrutiny of cost-cutting plans across the sector.

Türkiye manufacturing exit charge may keep regional operational risk and restructuring costs in focus for investors.

Restructuring-related margin pressure can affect broader autosupplier sentiment, though the article is company-specific.

Counterpoint

The revenue beat alongside the restructuring charge suggests underlying demand may be holding up, and the market may be over-discounting one-time costs.

Key entities

  • Autoliv

    Automotive safety systems provider that reported Q2 results and announced a Türkiye manufacturing exit restructuring charge.

  • Kevin Fox

    President of Autoliv Americas planning to step down for personal reasons.

Related articles

$ALVMed

ALV Downgraded by TD Cowen -- Price Target Lowered to $137.00

TD Cowen downgraded Autoliv (ALV) from 'Buy' to 'Hold' and lowered its price target from $148 to $137. The company's stock is currently trading at $120.16, which is 4.8% below its GF Value™ of $126.26. Autoliv has a GF Score™ of 84, indicating strong overall performance, particularly in profitability and valuation. Insiders have sold $2.55 million in shares over the last three months.

$ALVMed

Why is Autoliv stock sliding today?

Autoliv (ALV) stock fell 1.1% premarket after TD Cowen downgraded it from Buy to Hold, citing reduced analyst conviction. The company launched a new safety suite for virtual crash testing, with Toyota as the first customer. The broader U.S. market is also down, with the S&P 500 and Dow Jones Industrial Average declining 0.3% and 0.7%, respectively. ALV is currently trading at $123.83, below its 52-week high of $132.17.

$AVGOMed

Dow climbs as stocks rebound on earnings, falling Treasury yields

Tiziana Life Sciences (TLSA) received a Buy rating and $7 price target from BTIG. Ocean Power Technologies (OPTT) is using Palantir Foundry to improve operations. Sintana Energy (SEI) reported TotalEnergies' acquisition of a 40% interest in Namibia’s PEL 83. American Resources (AREC) joined the Critical Minerals Institute. Thistle Resources (TRCG) launched a Phase 3 drill program. BioHarvest Sciences (BHST) plans to dual-list on the Tel Aviv Stock Exchange. Alvopetro Energy (ALV) reported August

$ALVMed

Key facts: Allianz SE profits up; closes €2.53bn Singapore deals

Allianz SE reported higher profits, with operating profit up 9% YoY and core net income up 15.5% YoY for Q2/1H2026, citing strength in Asset Management, Property-Casualty, Asia, and a JV sale. The company said Solvency II coverage was 225% and noted ongoing buybacks. It also confirmed closing two Singapore deals: buying HSBC’s life and health unit for €2.1bn and acquiring UOB’s Singapore asset-management arm for about €430m.